Tumor Regression and Allograft Rejection after Administration of Anti-PD-1

N Engl J Med. 2016 Mar 3;374(9):896-8. doi: 10.1056/NEJMc1509268.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allografts
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / secondary
  • Female
  • Graft Rejection / chemically induced*
  • Humans
  • Immunocompromised Host
  • Kidney / metabolism
  • Kidney / pathology
  • Kidney Transplantation
  • Middle Aged
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors
  • Programmed Cell Death 1 Receptor / immunology*
  • Programmed Cell Death 1 Receptor / metabolism
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / secondary

Substances

  • Antineoplastic Agents
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor